Gefitinib With Anlotinib in Advanced Non-squamous NSCLC Patients With Uncleared Plasma ctDNA EGFRm After First-line Treatment With Gefitinib
Clinical trial NCT04358562 · UNKNOWN
Trial details
- NCT number
- NCT04358562
- Sponsor
- Second Affiliated Hospital of Nanchang University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2022-05-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.